Evaluate pathology AI tools for slide workflow fit, regulatory scope, image quality, lab validation, privacy, and pathologist oversight.
Pathology groups, health systems, digital pathology teams, oncology programs, laboratory directors, and AI governance committees.
Pathology AI depends on scanner, stain, tissue, LIS, and pathologist-review workflows, so validation has to happen inside the lab's actual diagnostic process.
| Medical risk | High |
|---|---|
| Best first step | Write the workflow in one sentence, decide who reviews the AI output, and test with a small controlled pilot before expanding. |
| Recommended posture | Use AI as supervised workflow support. Verify sources, privacy, human review, and regulatory fit before relying on outputs. |
These profiles are not rankings. They are starting points for checking vendor claims, privacy terms, FDA or regulatory posture, evidence, and workflow fit.
Paige describes AI applications for cancer pathology and a prostate suite for detection and diagnosis support.
Techcyte describes Fusion as a unified anatomic and clinical pathology AI platform with products for AP, frozen section, cervical cytology, parasitology, bacteriology, hematology, and organ donation workflows. Its site says Fusion includes image optimization, custom workflows and AI tools, IMS/viewer/storage, reporting and LIS integration, and compliance references including FDA, CE, HIPAA, ISO, GDPR, and SOC2. The footer states Techcyte is CE-IVDD marked in Europe and research use only in the US; buyers should verify current module-specific labeling before clinical use.
PathAI describes AISight Dx as a cloud-native digital pathology image-management system cleared for primary diagnosis in clinical settings; FDA records list K243391 for AISight Dx as digital pathology image viewing and management software, while PathAI product pages separately flag research-use AI tools and describe AISight Link LIS integration.
Roche describes navify Digital Pathology as enterprise pathology software for case workflow, multi-slide viewing, annotation, collaboration, cloud or on-prem deployment, scanner interoperability, PACS and navify Pathology Lab Hub integration, and access to AI-based image analysis algorithms through Roche Open Environment. Roche labeling materials describe Roche Digital Pathology Dx as an aid for qualified pathologists reviewing FFPE whole-slide images and state limits for other applications, while FDA records list Roche Digital Pathology Dx 510(k) clearances K232879 and K242783.
Open these vendor, documentation, privacy, or regulatory sources before relying on product claims, especially for FDA status, PHI handling, deployment model, and intended use.
Compare digital pathology products · Open the category shortlist · Review source policy
Find the best AI for medical workflows by matching the tool to documentation, questions, diagnosis support, research, coding, billing, imaging, or practice operations.
Compare AI tools for medical questions by source visibility, recency, hallucination controls, medical disclaimers, and clinician review.
Understand AI for medical diagnosis, including validation evidence, FDA status, clinical supervision, and why patient-specific diagnosis should not rely on general chatbots.
Evaluate AI for medical imaging by modality, intended use, FDA record, validation evidence, radiology workflow, and monitoring requirements.
Compare chest X-ray AI tools by finding scope, FDA or CE status, triage versus detection use, PACS workflow, privacy, and radiologist review.
Evaluate AI for medical charting by note quality, clinician review, EHR workflow, BAA terms, audio retention, and auditability.